FDA Form 483s for ISOThrive, Sciegen Pharmaceuticals, Richie Pharmacal, Cosmetic Essence, and Others

Original Request: Please provide the following inspection-related document(s) in electronic PDF format within Product Type Drugs: 1) The 483(s) (in electronic format) for the inspection of ISOThrive, Inc. (FEI 3011513461), located in Healdsburg, California, United States, inspection ending 2023-06-30, with project area(s): Bioresearch Monitoring. 2) The 483(s) (in electronic format) for the inspection of Sciegen Pharmaceuticals Inc (FEI 3008298016), located in Hauppauge, New York, United States, inspection ending 2023-04-21, with project area(s): Bioresearch Monitoring. 3) The 483(s) (in electronic format) for the inspection of Richie Pharmacal Company Inc (FEI 1025513), located in Glasgow, Kentucky, United States, inspection ending 2024-12-12. 4) The 483(s) (in electronic format) for the inspection of Cosmetic Essence, Inc. (FEI 1000222321), located in Ridgefield, New Jersey, United States, inspection ending 2024-12-06. 5) The 483(s) (in electronic format) for the inspection of Calumet Karns City Refining LLC (FEI 2517666), located in Karns City, Pennsylvania, United States, inspection ending 2024-12-04. etc
Tags: Pharma, 483, 2023